Gabapentin Capsule
Product Images NDC 50090-7674

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over an 8-week period, comparing placebo to Gabapentin at 3600 mg/day. The x-axis represents weeks with a 4-week dose titration period followed by a 4-week fixed dose period, and the y-axis displays mean pain scores ranging from 0 to 10. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis represents mean pain score ranging from 0 to 10. The graph marks a 3-week dose titration period followed by a 4-week fixed dose period, illustrating decreasing pain scores for both Gabapentin groups compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) treatments across two studies. The chart shows percentages of responders for placebo and gabapentin doses (3600 mg in Study 1, 1800 mg and 2400 mg in Study 2), with statistical significance annotations for gabapentin groups.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula illustrating the calculation of creatinine clearance (ClCr). It uses variables for age in years, weight in kilograms, serum creatinine in mg/dL, and includes an adjustment factor of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxylic acid group (CH2CO2H). The diagram depicts the molecular arrangement of Gabapentin's active ingredient.*

FDA Label Image

Image-09 (Image 09)

A scatter plot graph showing the difference percentage on the vertical axis and daily dose in milligrams on the horizontal axis. The graph compares data points from three studies labeled as Study a, Study b, and Study c, with doses ranging from 600 mg to 1800 mg. Data points are marked using different square symbols for each study.*

FDA Label Image

Label Image (Lbl500907674)

Label for Gabapentin 300 mg oral capsules by A-S Medication Solutions. The label indicates a package of 30 capsules, with storage instructions to keep at 68 to 77 degrees Fahrenheit. Includes a QR code and package identification details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.